Login to Your Account

Financings Roundup

Friday, May 13, 2011
SpringLeaf Therapeutics Inc., of Boston, raised $15 million in a Series B financing to develop its drug-device combination system for the subcutaneous delivery of biologics. New investor SR One led the round, with participation from existing investors Flybridge Capital Partners and North Bridge Venture Partners.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription